Product
Tc 99m EC20
5 clinical trials
9 indications
Indication
Ovarian CancerIndication
Endometrial CancerIndication
Renal Cell CarcinomaIndication
CancerIndication
Head and Neck CancerIndication
Pancreatic CancerIndication
Bladder CancerIndication
Testicular CancerIndication
Healthy Control ParticipantsClinical trial
A Multi-center Clinical Study to Evaluate the Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell CarcinomaStatus: Completed
Clinical trial
A MULTI-CENTER CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF FOLATESCAN (TECHNETIUM Tc 99m EC20) IN PATIENTS WITH SUSPECTED OVARIAN CARCINOMA OR RECURRENT ENDOMETRIAL CARCINOMAStatus: Completed
Clinical trial
A Phase II Clinical Study to Evaluate the Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid TumorStatus: Completed
Clinical trial
A Multi-center Clinical Study to Evaluate the Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial CancerStatus: , Estimated PCD: 2004-08-01